Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of AMRX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1553154+2
Shares100.4M16.3M100.8M+16.7M (+19.9%)
Value$535.3M$87.2M$481.1M+$33.0M (+7.4%)

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (20)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to AMRX in Q4 2021
InstitutionSharesValue% of portfolio
TPG GP A, LLC16,213,367$77.7M0.77%
Allspring Global Investments Holdings, LLC447,700$2.14M0.00%
PDT Partners, LLC110,566$530.0K0.04%
Simplex Trading, LLC96,998$464.0K0.02%
Hedges Asset Management LLC75,000$359.0K0.28%
HSBC Holdings PLC56,107$272.0K0.00%
Gsa Capital Partners LLP33,402$160.0K0.02%
Campbell & CO Investment Adviser LLC26,700$128.0K0.04%
Grantham, Mayo, Van Otterloo & Co. LLC24,400$117.0K0.00%
ExodusPoint Capital Management, LP23,292$112.0K0.00%
State of Wyoming19,956$96.0K0.04%
Janus Henderson Group PLC19,621$94.0K0.00%
Covestor Ltd6,619$32.0K0.04%
National Bank of Canada1,800$9.00K0.00%
Snowden Capital Advisors LLC1,561$7.00K0.00%
Rise Advisors, LLC500$2.40K0.00%
The PNC Financial Services Group, Inc.200$1.00K0.00%
JFS Wealth Advisors, LLC6$00.00%
Charter Oak Capital Management, LLC25$00.00%
Fortitude Advisory Group L.L.C.57$00.00%

Sold out (18)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (3)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMRX in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
TPG Group Holdings (SBS) Advisors, Inc.16,213,367$86.6M
Marshall Wace North America L.P.116,469$621.0K
Berman Capital Advisors, LLC329$1.00K